Evidence map›Paper›PMID 29281819›Full record

ArticleCell reports2017

Rlim-Dependent and -Independent Pathways for X Chromosome Inactivation in Female ESCs.

Feng Wang, Kurtis N McCannell, Ana Bošković, Xiaochun Zhu, JongDae Shin, Jun Yu, Judith Gallant, Meg Byron, Jeanne B Lawrence, Lihua J Zhu and 4 more

Abstract read
In one paragraph

Article in Cell reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Roles of the Rlim-Rex1 axis during X chromosome inactivation in mice.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Rlim/Rnf12, Rex1, and X Chromosome Inactivation.Frontiers in cell and developmental biology · 2019
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Feng WangDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Kurtis N McCannellDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Ana BoškovićDepartment of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Xiaochun ZhuDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
JongDae ShinDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Jun YuDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Judith GallantDepartment of Cell and Developmental Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Meg ByronDepartment of Cell and Developmental Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Jeanne B LawrenceDepartment of Cell and Developmental Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Lihua J ZhuDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA; Program in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Stephen N JonesDepartment of Cell and Developmental Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Oliver J RandoDepartment of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Thomas G FazzioDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Ingolf BachDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA. Electronic address: ingolf.bach@umassmed.edu.

Funding

PILOT AND FEASIBILITY PROGRAMP30DK032520 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CZECH, MICHAEL P · 1986 to 2010
$14.6M
Dietary effects on the sperm epigenomeR01HD080224 · NICHD · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI RANDO, OLIVER J · 2014 to 2022
$5.9M
Roles of Chromatin Regulation in Embryonic Stem Cell Self-RenewalR01HD072122 · NICHD · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Thomas G Fazzio · 2012 to 2026
$5.9M
The Role of MDM Proteins in Cell Growth and TumorigenesisR01CA077735 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI JONES, STEPHEN, ZHANG, HONG · 1999 to 2019
$5.7M
RNA and Genomic Junk in Fundamental Chromosome Architecture and RegulationR35GM122597 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI JEANNE Bentley LAWRENCE · 2017 to 2026
$5.3M
XIST RNA: A Key to Understand Epigenome Regulation and Chromosome StructureR01GM053234 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LAWRENCE, JEANNE BENTLEY · 1996 to 2017
$5.1M
tRNA fragments as transgenerational information carriersDP1ES025458 · NIEHS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI RANDO, OLIVER J · 2014 to 2018
$4.2M
Roles of LIM cofactors for regulating ERalpha during oncogenesis and developmentR01CA131158 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BACH, INGOLF M · 2008 to 2017
$3.3M
NCI NIH HHS R01 CA077735NCI NIH HHS R01 CA131158NICHD NIH HHS R01 HD072122NICHD NIH HHS R01 HD080224NIDDK NIH HHS P30 DK032520NIEHS NIH HHS DP1 ES025458NIGMS NIH HHS R01 GM053234NIGMS NIH HHS R35 GM122597
6 · The paper itself

Abstract

During female mouse embryogenesis, two forms of X chromosome inactivation (XCI) ensure dosage compensation from sex chromosomes. Beginning at the four-cell stage, imprinted XCI (iXCI) exclusively silences the paternal X (Xp), and this pattern is maintained in extraembryonic cell types. Epiblast cells, which give rise to the embryo proper, reactivate the Xp (XCR) and undergo a random form of XCI (rXCI) around implantation. Both iXCI and rXCI depend on the long non-coding RNA Xist. The ubiquitin ligase RLIM is required for iXCI in vivo and occupies a central role in current models of rXCI. Here, we demonstrate the existence of Rlim-dependent and Rlim-independent pathways for rXCI in differentiating female ESCs. Upon uncoupling these pathways, we find more efficient Rlim-independent XCI in ESCs cultured under physiological oxygen conditions. Our results revise current models of rXCI and suggest that caution must be taken when comparing XCI studies in ESCs and mice.

Indexed as

AnimalsCell Culture TechniquesFemaleMiceMouse Embryonic Stem CellsMutant ProteinsUbiquitin-Protein LigasesX Chromosome InactivationMutant ProteinsRlim protein, mouseUbiquitin-Protein LigasesEB differentiationESCphysiological oxygen levelsRlimRlim-independent XCIRnf12X chromosome inactivationXCIXCI regulationXist

Identifiers

PMID29281819
PMCPMC5747310

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.